Use of meloxicam (Amelotex®) in patients with chronic gout to prevent
https://doi.org/10.14412/1996-7012-2011-698
Abstract
The paper presents the results of a trial of the efficacy and safety of the nonsteroidal anti-inflammatory drug Amelotex® (meloxicam) used to prevent episodes of arthritis in patients with gout during initiation of allopurinol therapy. The study has demonstrated that one-month therapy with Amelotex® can minimize the risk of arthritis exacerbations when allopurinol is used. Amelotex® shows a good tolerability and causes the low rates of side effects
References
1. <div><p>Насонова В.А., Барскова В.Г. Ранние диагностика и лечение подагры - научно обоснованное требование улучшения трудового и жизненного прогноза больных. Науч-практич ревматол 2004;1:5-7.</p><p>Zhang W., Doherty M., Bardin T. et al. EULAR evidence based recommendation for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;65(10):1312-24</p><p>;65(10):1312-24Mandell B.F., Edwards N.L., Sundy J.S. et al. Preventing and treating acute gout attacks across the clinical spectrum: A roundtable discussion. Cleveland clin j med 2010;77(Suppl. 2):S2-S25.</p><p>Березовская И.В. Сравнительное изучение общетоксического действия мелоксикама (ЗАО «Фармфирма «СОТЕКС», Россия) с мовалисом (BOEHRINGER INGELHEIM ESPANA S.A., Испания). Купавна, 2006;51.</p><p>Wallace S.L., Robinson H., Masi A.T. et al. Preliminary criteria for the classification of the acute arthritis of gout. Arthr Rheum 1977;20:895-900</p><p>Sundy J.S. Progress in the pharmacotherapy of gout. Current Opinion in Rheumatology 2010;22:188-93</p><p>Perez-Ruiz F. Treating to target: a strategy to cure gout. Rheumatology 2009;48:ii9-ii14.</p><p>Барскова В.Г. Метаболический синдром и кардиоваскулярные нарушения при подагре. Дисс. ... докт. мед. наук, М., 2006</p><p>Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol 2004;31:1575-81.</p><p>Becker M.A., Schumacher H.R. Jr., Wortmann R.L. et al. Febuxostat compared with allopurinol in patients with hyper- uricemia and gout. N Engl J Med 2005;353:2450-61</p></div><br />
Review
For citations:
Eliseyev MS, Vladimirov SA. Use of meloxicam (Amelotex®) in patients with chronic gout to prevent. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2011;5(4):49-52. (In Russ.) https://doi.org/10.14412/1996-7012-2011-698
Views:
24397
Email this article 